Davis S - Search Results

1

5-Fluorouracil and isoprinosine in the treatment of advanced colorectal cancer. A limited phase I, II evaluation.

Colozza M, Tonato M, Belsanti V, Mosconi AM, Fiorucci S, Gernini I, Rambotti P, Davis S. Colozza M, et al. Among authors: davis s. Cancer. 1988 Sep 15;62(6):1049-52. doi: 10.1002/1097-0142(19880915)62:6<1049::aid-cncr2820620604>3.0.co;2-k. Cancer. 1988. PMID: 2457421

2

Chemotherapy with cis-platin, doxorubicin, and cyclophosphamide (CAP) in patients with metastatic breast cancer.

Colozza M, Gori S, Mosconi AM, Belsanti V, Basurto C, Rossetti R, Di Costanzo F, Buzzi F, Bacchi M, Davis S, et al. Colozza M, et al. Among authors: davis s. Am J Clin Oncol. 1989 Apr;12(2):137-41. doi: 10.1097/00000421-198904000-00010. Am J Clin Oncol. 1989. PMID: 2705403

3

Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study.

Davis S, Tonato M, Crinò L, Colozza MA, Lubansky K, Grignani F. Davis S, et al. Cancer. 1986 Sep 1;58(5):1018-9. doi: 10.1002/1097-0142(19860901)58:5<1018::aid-cncr2820580505>3.0.co;2-q. Cancer. 1986. PMID: 3015372

4

Low-dose mitomycin and weekly low-dose doxorubicin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, and 5-fluorouracil.

Colozza M, Tonato M, Grignani F, Davis S. Colozza M, et al. Among authors: davis s. Cancer. 1988 Jul 15;62(2):262-5. doi: 10.1002/1097-0142(19880715)62:2<262::aid-cncr2820620206>3.0.co;2-c. Cancer. 1988. PMID: 3383126

5

Metastatic spindle cell carcinoma: a complete response induced by cisplatin and 5-fluorouracil.

Colozza M, Grignani F, Crino L, Tonato M, Davis S. Colozza M, et al. Among authors: davis s. Anticancer Res. 1988 May-Jun;8(3):457-8. Anticancer Res. 1988. PMID: 3389747

6

Combination cyclophosphamide, doxorubicin, and cisplatin (CAP) chemotherapy for extensive non-small cell carcinomas of the lung.

Davis S, Rambotti P, Park YK. Davis S, et al. Cancer Treat Rep. 1981 Nov-Dec;65(11-12):955-8. Cancer Treat Rep. 1981. PMID: 7028257 Clinical Trial.

7

Expression of aphidicolin-induced fragile sites in lymphocytes of patients with breast cancer.

Ardisia C, Venti G, Colozza MA, Breschi C, Porfirio B, Davis S, Tonato M, Donti E. Ardisia C, et al. Among authors: davis s. Cancer Genet Cytogenet. 1993 Jun;67(2):113-6. doi: 10.1016/0165-4608(93)90162-f. Cancer Genet Cytogenet. 1993. PMID: 8330266

8

A prospective analysis of chemotherapy following surgical resection of clinical stage I-II small-cell lung cancer.

Davis S, Crino L, Tonato M, Darwish S, Pelicci PG, Grignani F. Davis S, et al. Am J Clin Oncol. 1993 Apr;16(2):93-5. doi: 10.1097/00000421-199304000-00001. Am J Clin Oncol. 1993. PMID: 8383917

9

Vindesine and mitomycin C in chemotherapy: refractory advanced breast cancer.

Di Costanzo F, Gori S, Tonato M, Buzzi F, Crino L, Grignani F, Davis S. Di Costanzo F, et al. Among authors: davis s. Cancer. 1986 Mar 1;57(5):904-7. doi: 10.1002/1097-0142(19860301)57:5<904::aid-cncr2820570503>3.0.co;2-4. Cancer. 1986. PMID: 3002594

10

Single-agent and combination chemotherapy for extensive non-small cell carcinomas of the lung.

Davis S, Pandya MR, Rambotti P. Davis S, et al. Cancer Treat Rep. 1980 Apr-May;64(4-5):685-8. Cancer Treat Rep. 1980. PMID: 6253067 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,627 results

Search Page

Filters